Earnings Ahead

LLY - Eli Lilly & Co

804.62 -16.57 -2.02

Eli Lilly & Co

Eli Lilly & Co

About

Profile

Lilly was founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed was thi


Headquarters

Indianapolis, Indiana, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

LLY

Eli Lilly shares moved slightly higher after the Food and Drug Administration approved the drug makers Alzheimers treatment know as donanemab. The drug will be sold under the brand name Kisunla and used for adults with early symptoms. Shares dipped about 1% during Tuesdays session.


 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Lilly reportedly worried about impact of Catalent/Novo deal
  • Eli Lilly hurts NASH drug developers after mid-stage win for obesity therapy
  • Biggest stock movers today: DocuSign, BP, Palantir Technologies, and more
  • 6 stocks to watch on Tuesday: Spotify, Eli Lilly, Chipotle, DocuSign and more
  • Eli Lilly in charts: Verzenio and Mounjaro drive revenue growth, while Humalog and Trulicity decline
  • Eli Lilly beats in Q4 as obesity drug sales blow past estimates
  • Eli Lilly beats top-line and bottom-line estimates; initiates FY24 outlook
  • Eli Lilly Q4 results to highlight Zepbound uptake
  • Eli Lilly sees highest intraday trade since November ahead of earnings
  • Progressive and Universal Health are added into BofA’s Growth screen for February
  • Amgen weight loss drug shows promising early data
  • Catalyst watch: Alibaba earnings, World Defense Show, Fed speakers unleashed and Super Bowl buzz
  • AbbVie cites tailwinds to Botox business from weight loss drugs
  • Lilly, Zoetis, Abbott least shorted stocks in S&P 500 health sector in mid-Jan
  • U.S. govt. opens bids in Medicare drug price negotiations
  • NeuroBo to begin Phase 1 testing of potential Wegovy rival
  • Lilly, Novo could be first trillion-dollar health stocks: world's largest sovereign wealth fund
  • Eli Lilly wins Canada approval for severe hair loss therapy
  • Karuna’s KarXT tops Evaluate’s most anticipated drug list
  • Eli Lilly said to be in talks with Germany to win coverage for weight loss drugs

Earnings History

Date EPS / Forecast Revenue / Forecast
February 3, 2022 2.49 / 2.45 8B / 7.69B Beat!
October 26, 2021 1.94 / 1.96 6.77B / 6.64B Beat!
August 3, 2021 1.87 / 1.89 6.74B / 6.6B Beat!
April 27, 2021 1.87 / 2.12 6.81B / 6.93B
January 29, 2021 2.75 / 2.37 7.44B / 7.27B Beat!
October 27, 2020 1.54 / 1.71 5.74B / 5.88B
July 30, 2020 1.89 / 1.56 5.5B / 5.76B
April 23, 2020 1.75 / 1.48 5.86B / 5.49B Beat!
January 30, 2020 1.73 / 1.52 6.11B / 5.91B Beat!
October 23, 2019 1.48 / 1.4 5.48B / 5.5B
July 30, 2019 1.5 / 1.45 5.64B / 5.58B Beat!
April 30, 2019 1.33 / 1.31 5.09B / 5.2B
February 6, 2019 1.33 / 1.34 6.44B / 6.29B Beat!
November 6, 2018 1.39 / 1.35 6.06B / 6.03B Beat!
July 24, 2018 1.5 / 1.3 6.36B / 6.05B Beat!
April 24, 2018 1.34 / 1.13 5.7B / 5.52B Beat!
January 31, 2018 1.14 / 1.07 6.16B / 5,934M Beat!
October 24, 2017 1.05 / 1.03 5.66B / 5.52B Beat!
July 25, 2017 1.11 / 1.05 5.82B / 5.60B Beat!
April 25, 2017 0.98 / 0.96 5.23B / - Beat!
Date Price Open High Low Vol Change
Jul 24 859.88 872.5
878.34
854.27
2.7M -2.1%
Jul 23 878.29 870
887.72
864.08
2.1M 1.42%
Jul 22 865.97 864.8
874.42
856.82
2.9M 0.99%
Jul 19 857.47 867.66
880.21
853
3.8M 1.01%
Jul 18 848.9 907.03
909.87
836.66
7.6M -6.26%
 
Jul 17 905.59 910.01
925
902.64
4.2M -3.82%
Jul 16 941.6 955.75
956.39
938.38
2.1M -0.93%
Jul 15 950.46 956.2
966.1
948.09
2.4M 0.22%
Jul 12 948.4 937
950.79
936.03
2.3M 1.53%
Jul 11 934.14 934.09
942.88
918.62
2.9M -0.6%
Jul 10 939.78 936.57
945.69
933
2.7M 0.78%
Jul 9 932.5 929.05
935
920.78
2.4M 1.58%
Jul 8 918 917.89
928.6
912
2.4M 0.38%
Jul 5 914.57 898.42
916.46
896.9
2.9M 1.83%
Jul 3 898.1 911
918.5
884
3.1M -0.95%
Jul 2 906.71 902.71
912
878.5
4.6M -0.84%
Jul 1 914.37 911.77
916.83
904.31
2.5M 0.99%
Jun 28 905.38 911.31
915.54
905.38
3.4M -0.4%
Jun 27 909.04 903.53
909.57
899.72
1.9M 0.86%
Jun 26 901.26 904
906.34
897.84
2.2M -0.37%
Jun 25 904.61 891.77
909.42
891.5
2.8M 1.63%
Jun 24 890.11 889.97
903.58
882.94
2.9M 0.70%
Jun 21 883.88 885.66
891.97
879.8
3.4M -0.24%
Jun 20 885.99 893
905.45
870.13
3.4M -0.61%
Jun 18 891.46 887
894.87
884
2.4M 0.73%
Jun 17 885.01 878
892.2
876.86
2.5M 0.75%
Jun 14 878.45 882.33
884.61
876
2.0M -0.55%
Jun 13 883.33 869.03
885.06
861.5
2.2M 1.85%
Jun 12 867.3 872
872
853.85
2.6M 0.17%
Jun 11 865.82 882.14
882.14
852.23
4.1M 0.09%
Jun 10 865 853.98
871.63
849.39
3.4M 1.77%
Jun 7 849.99 837.76
856.81
837.01
2.5M 1.52%
Jun 6 837.29 834.88
846.97
831.88
2.1M 0.66%
Jun 5 831.76 830.49
838.45
817.62
2.2M -0.1%
Jun 4 832.59 834
835.47
825.31
1.7M 0.16%
Jun 3 831.26 823.83
838.28
818.5
2.5M 1.33%
May 31 820.34 818.8
826.21
811.1
4.5M 0.65%
May 30 815.06 812.79
819.99
806.11
2.0M 0.43%
May 29 811.53 803
815.61
802.09
2.4M 0.45%
May 28 807.86 809
809
788.25
2.5M 0.05%
May 24 807.43 808
810.12
804.15
1.8M -0.13%
May 23 808.45 810
820.6
802.16
3.0M 0.69%
May 22 802.91 801
804.88
795.25
1.8M -0.03%
May 21 803.17 792.46
816.61
791.39
4.3M 2.55%
May 20 783.18 766.9
784.33
766.12
2.2M 1.71%
May 17 770 772.89
774.87
767.1
1.7M -0.15%
May 16 771.12 784.71
786.48
770.14
2.3M -2.02%
May 15 787.02 764.15
787.66
763.1
3.0M 3.02%
May 14 763.98 751.52
764.5
751.52
2.0M 0.83%
May 13 757.7 763.5
763.55
750.53
1.8M -0.3%
May 10 760 774.02
777.42
760
2.1M -1.5%
May 9 771.55 777
784
769.2
2.5M -0.45%
May 8 775 779.1
781.35
772.2
2.1M -0.36%
May 7 777.77 768.9
779.09
762.11
2.9M 1.45%
May 6 766.68 738.04
766.99
736
3.4M 4.31%
May 3 734.97 743
745
730.34
4.6M -2.77%
May 2 755.91 777.34
777.34
754.29
3.2M -2.68%
May 1 776.75 774.76
782.6
768.25
2.8M -0.56%
Apr 30 781.1 775
795.5
767.66
7.4M 5.95%
Apr 29 737.2 735.75
740.58
729.61
2.7M 0%